Checked Aug 3, 2026
How much does Zepbound cost without insurance in 2026?
Zepbound costs $1,086 a month at retail without insurance. Most people pay far less. LillyDirect sells single-dose vials direct for $299 to $449 a month, and compounded tirzepatide, the same active ingredient, starts at $278 a month where supply remains. Here is every cash path and what each one really costs.
Zepbound costs about $1,086 a month at retail without insurance. Almost no one pays that. LillyDirect sells single-dose vials direct for $299 to $449 a month depending on dose. Compounded tirzepatide, the same active ingredient, starts at $278 a month where supply remains.
- Retail price, no insurance: about $1,086 a month. The typical cash price for the Zepbound KwikPen at a US pharmacy. It is a sticker number, not what most people pay.
- Cheapest branded route: $299 a month. LillyDirect self-pay vials at the 2.5mg and 5mg starter doses. The price rises to $449 a month at higher doses.
- Cheapest tirzepatide overall: $278 a month. Compounded tirzepatide at Mochi, month-to-month with no lock-in. Same active ingredient, prepared by a licensed pharmacy, supply narrowing under litigation.
- With insurance: $25 to $50 a month. A typical copay once a plan approves Zepbound for obesity. The hurdle is prior authorization.
- Medicare: $50 a month, pen only. The GLP-1 Bridge opened July 1, 2026 and covers the Zepbound KwikPen for weight loss at $50 a month if you qualify. Before that, Medicare paid only for sleep apnea.
- The cash gap is about $800 a month. The distance between the $299 LillyDirect starter vial and the $1,086 retail price, for the same molecule.
Every Zepbound cash path, side by side
Zepbound is tirzepatide, made by Eli Lilly and approved for chronic weight management in 2023. It is the only dual GLP-1 and GIP receptor agonist approved for obesity. There are four ways to pay for it without insurance, and the price gap between them is large. These are ongoing prices, not multi-month prepay teasers.
| Path | Cost / mo | Cost / year | Source |
|---|---|---|---|
| Compounded tirzepatide (same active ingredient) | $278 to $349 | $3,336 to $4,188 | Mochi $278, Price Index |
| LillyDirect self-pay vials (branded) | $299 to $449 | $3,588 to $5,388 | LillyDirect |
| Amazon Pharmacy Zepbound KwikPen (branded) | from $299 | from $3,588 | Cash price shown at checkout. No membership fee. |
| Zepbound through a telehealth program (branded) | $373 to $598 | $4,476 to $7,176 | Compare programs |
| Zepbound KwikPen, retail cash (no program) | about $1,086 | about $13,188 | Zepbound drug page |
Prices are checked every Monday against LillyDirect's published pricing and each program's published pricing, then logged on the Price Index. We do not create accounts or make purchases to verify them.
The $299 LillyDirect vials, explained
The cheapest branded route is LillyDirect, Eli Lilly's direct-to-consumer cash program. It sells single-dose Zepbound vials, drawn with a syringe rather than the pre-filled KwikPen, at $299 a month for the 2.5mg and 5mg doses. The vials hold the same tirzepatide as the branded pen.
The catch is the dose. The $299 price is for the two starter doses. As you titrate up the weeks of dose ramp-up before you reach your steady dose to a maintenance dose, the monthly price climbs toward $449. Treat $299 as the entry price, not the long-term price, and confirm your maintenance-dose cost on LillyDirect before you commit.
Compounded tirzepatide: the same molecule for $278
Compounded tirzepatide is the same active ingredient as Zepbound, prepared for an individual patient by a licensed 503A compounding pharmacy. It is not the branded Zepbound product and is not reviewed as a finished drug. At $278 a month it undercuts the $299 LillyDirect vial by about $21, at the cost of losing the manufacturer brand chain.
The floor is $278 a month at Mochi, flat at every dose, billed month-to-month with no lock-in. Most other compounding programs land between $278 and $349. Supply has tightened sharply through 2025 and 2026 because Eli Lilly has filed coordinated lawsuits against compounded tirzepatide pharmacies, so check the live price and availability before you sign up. If supply is a concern, the $299 LillyDirect vial is the branded fallback at a similar price.
What Zepbound costs with insurance
When a commercial plan covers Zepbound for obesity, the copay usually runs $25 to $50 a month. That is the cheapest path of all, but it is gated by prior authorization. Most plans require a BMI of 30 or higher, or 27 with a weight-related condition, plus documentation. The review takes one to six weeks and is often denied on the first try, and a growing number of employer plans exclude weight-loss drugs entirely.
Whether your plan covers Zepbound at all depends on the payer. Check our payer coverage pages for your insurer. If prior authorization is required, our PA letter templates cover the major commercial payers. If you are denied, the appeal letter builder drafts the response. Medicare covers Zepbound for obstructive sleep apnea. Since July 1, 2026, the Medicare GLP-1 Bridge has covered qualifying Part D beneficiaries at a flat $50 a month, for the KwikPen only.
What Zepbound costs per year
Zepbound is a long-term medication, so the annual number is the one that matters. A year of retail Zepbound costs about $13,188 with no insurance. LillyDirect starter vials at $299 a month are about $3,588 a year, and compounded tirzepatide at $278 a month is $3,336 a year. With insurance covering the drug, a year can cost as little as $300 to $600 in copays.
The gap between the cheapest branded route and retail cash is about $800 a month, or roughly $9,600 a year, for the same molecule. That gap is the whole reason to compare before you start.
Why Zepbound is so expensive in the US
The $1,086 retail price is a US phenomenon. The same tirzepatide costs a fraction of that in Europe. The US has no central drug-price negotiation, and pharmacy-benefit managers capture much of the rebate between list and net price. The retail figure is mostly a sticker. The real cash floor is the $299 LillyDirect vial and the $278 compounded path.
Zepbound earns its price on results. In the SURMOUNT-1 registration trial (NEJM, 2022), patients lost a mean of 20.9% of body weight over 72 weeks at the top dose, with 91% losing at least 5%. That is the strongest mean weight loss of any branded GLP-1 in head-to-head trial data. The clinical case is strong. The pricing case is what this page is for.
What to do next
If you want branded Zepbound, start with LillyDirect for the $299 starter vial, then check whether your insurance will cover the KwikPen. If you want the lowest cash price and are open to compounded tirzepatide, Mochi's $278 flat rate is the floor we track, with the litigation caveat. Compare every program's real all-in price on the GLP Chart, and read the full Zepbound buyer's guide before you decide. If you have type 2 diabetes, the same molecule is sold as Mounjaro; the Mounjaro cost guide covers that route. If you are weighing it against semaglutide, the Wegovy cost guide covers that side.
Zepbound cost FAQ
How much does Zepbound cost without insurance?
Zepbound's retail cash price without insurance is about $1,086 a month. Almost no one pays that. LillyDirect, Eli Lilly's direct cash program, sells single-dose vials for $299 to $449 a month depending on dose. Compounded tirzepatide, the same active ingredient, starts at $278 a month at Mochi where supply remains available.
What is the cheapest way to get Zepbound?
The cheapest branded route is LillyDirect self-pay vials, which start at $299 a month for the 2.5mg and 5mg starter doses and run up to $449 a month at higher doses. The cheapest tirzepatide route overall is compounded tirzepatide at $278 a month through Mochi, billed month-to-month with no lock-in. It is the same active ingredient as Zepbound, prepared by a licensed compounding pharmacy.
How much does Zepbound cost per month with insurance?
When a commercial plan covers Zepbound for obesity, the copay typically runs $25 to $50 a month. The hurdle is prior authorization, which usually requires a BMI of 30 or higher (or 27 with a weight-related condition) and often takes one to six weeks. Many plans deny the first request, and a growing number of employer plans exclude weight-loss drugs entirely.
What are LillyDirect Zepbound vials?
LillyDirect is Eli Lilly's direct-to-consumer cash program. It sells Zepbound at $299 a month at 2.5mg, $399 at 5mg and $449 at 7.5mg and above, as single-dose vials drawn with a syringe or as the multi-dose KwikPen, both at the same price. Read the refill rule before you budget: Lilly holds those prices on your first fill and on refills placed within 45 days of the last one. Miss the window and Lilly bills its regular price instead, $499 at 7.5mg and $699 at 10mg and above. The program pricing itself ends December 31, 2026. Either format is the same tirzepatide as the branded pen, priced well below the $1,086 retail cash price.
Is compounded tirzepatide the same as Zepbound?
Compounded tirzepatide is the same active ingredient as Zepbound, prepared for an individual patient by a licensed 503A compounding pharmacy. It is not the branded Zepbound product and is not reviewed as a finished drug. It costs $278 to $349 a month cash. Supply has narrowed sharply through 2025 and 2026 because Eli Lilly has filed coordinated lawsuits against compounded tirzepatide pharmacies, so confirm the live price before you sign up.
Why is Zepbound so expensive in the US?
Eli Lilly sets the US retail price near $1,086 a month, far above the price in Europe, because the US has no central drug-price negotiation and pharmacy-benefit middlemen capture much of the rebate. The retail figure is mostly a sticker. The real cash floor is the $299 LillyDirect starter vial and the $278 compounded path.
What does Zepbound cost through telehealth programs?
The cheapest cash route to branded Zepbound is LillyDirect vials at $399 a month at the 5mg maintenance dose, $299 at the starter dose. That is Eli Lilly selling straight to you, no membership. Through a telehealth program you add a membership on top: Ro is $373 and Hims is $598, which is $449 for the medication plus $149 for the membership. Compounded tirzepatide starts at $278 at Mochi. The live chart has every program's all-in price.
How much does a year of Zepbound cost?
A year of retail-price Zepbound costs about $13,188 with no insurance. LillyDirect starter vials at $299 a month work out to about $3,588 a year, and compounded tirzepatide at $278 a month is $3,336 a year. With insurance covering the drug, a year can cost as little as about $300 to $600 in copays.
Does Medicare cover Zepbound?
Since July 1, 2026, the Medicare GLP-1 Bridge covers qualifying GLP-1s at a flat $50 a month for eligible Part D beneficiaries who meet CMS clinical criteria. On this drug it covers the KwikPen only, not the single-dose vials or pens, so ask your prescriber to write the KwikPen. Before July 2026, Medicare paid for it only under the obstructive sleep apnea indication in adults with obesity, never for weight loss alone.
Will the price of Zepbound go down?
Lilly has already cut the effective cash price by launching LillyDirect self-pay vials at $299 to $449 a month, far below the $1,086 retail price. Compounded tirzepatide pressure is the other lever, though litigation has narrowed that supply. We check Zepbound pricing every Monday and log changes on the Price Index.
